CATERPILLAR INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CATERPILLAR INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.59B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $64.81B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $67.06B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $59.43B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $50.97B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $11.24B | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $9.88B | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $10.00B | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | $10.64B | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | $13.14B | Feb 17, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $12.19B | Feb 15, 2018 |
| FY2017 | Sep 30, 2017 | $10.71B | Feb 15, 2018 |
| FY2017 | Jun 30, 2017 | $10.64B | Feb 15, 2018 |
| FY2017 | Mar 31, 2017 | $9.13B | Feb 15, 2018 |
| FY2017 | Dec 31, 2016 | $8.89B | Feb 15, 2018 |
| FY2017 | Sep 30, 2016 | $8.46B | Feb 15, 2018 |
| FY2017 | Jun 30, 2016 | $9.65B | Feb 15, 2018 |
| FY2017 | Mar 31, 2016 | $8.78B | Feb 15, 2018 |
| FY2016 | Dec 31, 2015 | $10.32B | Feb 15, 2017 |
| FY2016 | Sep 30, 2015 | $10.29B | Feb 15, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.79B | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | $2.31B | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | $2.20B | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | $2.65B | Feb 17, 2021 |
| FY2019 | Dec 31, 2019 | $3.27B | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $3.41B | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $3.73B | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $3.72B | Feb 19, 2020 |
| FY2018 | Dec 31, 2018 | $3.64B | Feb 14, 2019 |
| FY2018 | Sep 30, 2018 | $3.74B | Feb 14, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $968.00M | Feb 22, 2011 |
| FY2010 | Sep 30, 2010 | $792.00M | Feb 22, 2011 |
| FY2010 | Jun 30, 2010 | $707.00M | Feb 22, 2011 |
| FY2010 | Mar 31, 2010 | $233.00M | Feb 22, 2011 |
| FY2010 | Dec 31, 2009 | $232.00M | Feb 22, 2011 |
| FY2010 | Sep 30, 2009 | $404.00M | Feb 22, 2011 |
| FY2010 | Jun 30, 2009 | $371.00M | Feb 22, 2011 |
| FY2010 | Mar 31, 2009 | ($112.00M) | Feb 22, 2011 |
| FY2009 | Dec 31, 2008 | $3.56B | Feb 19, 2010 |
| FY2009 | Dec 31, 2007 | $3.54B | Feb 19, 2010 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.15B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $13.07B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $12.97B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $7.90B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $6.88B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $4.55B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $8.29B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $8.29B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $4.46B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $1.16B | Feb 14, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.15B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.11B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $2.11B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.81B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.69B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.42B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $1.69B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.85B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.84B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $1.85B | Feb 14, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.99B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.67B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.37B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $5.65B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $5.37B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $4.64B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $5.16B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $5.48B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $5.00B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $4.38B | Feb 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.74B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $12.04B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $12.89B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $7.77B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $7.20B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $6.33B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $6.91B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $6.56B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $5.71B | Feb 19, 2020 |
| FY2010 | Dec 31, 2010 | $5.01B | Feb 22, 2011 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.82B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.99B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.60B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.30B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.09B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $978.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $1.06B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.28B | Feb 17, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $98.59B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $87.76B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $87.48B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $81.94B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $82.79B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $78.32B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $78.45B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $78.51B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $76.96B | Feb 14, 2019 |
| FY2018 | Dec 31, 2016 | $74.70B | Feb 14, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.27B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $68.27B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $67.97B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $66.05B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $66.28B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $62.95B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $63.82B | Feb 17, 2021 |
| FY2019 | Dec 31, 2018 | $64.43B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $63.20B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $61.49B | Feb 15, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.32B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.24B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $5.31B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $5.29B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $6.32B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $6.39B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $6.20B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $6.22B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $6.20B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $6.02B | Feb 14, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.45B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $59.35B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $51.25B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $43.51B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $39.28B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $35.17B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $34.44B | Feb 17, 2021 |
| FY2019 | Jan 1, 2019 | $30.66B | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $30.43B | Feb 19, 2020 |
| FY2018 | Jan 1, 2018 | $26.29B | Feb 14, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.98B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.89B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $6.98B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $7.00B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $9.25B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $9.35B | Feb 16, 2022 |
| FY2009 | Dec 31, 2009 | $4.87B | Feb 19, 2010 |
| FY2009 | Dec 31, 2008 | $2.74B | Feb 19, 2010 |
| FY2009 | Dec 31, 2007 | $1.12B | Feb 19, 2010 |
| FY2009 | Dec 31, 2006 | $530.00M | Feb 19, 2010 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 22 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 20 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 22 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 20 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 17, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 17, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 465.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 477.90M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 499.40M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 516.30M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 535.90M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 545.30M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | 550.10M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | 575.50M | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | 597.60M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | 586.50M | Feb 14, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.65B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $2.56B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $2.44B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.33B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $2.24B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $2.13B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $1.95B | Feb 17, 2021 |
| FY2019 | Dec 31, 2017 | $1.83B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $1.80B | Feb 14, 2019 |